04.11.2015
- Ireland-based and London-listed drugmaker Shire has agreed what is being called a “defensive” deal to buy US biotech firm Dyax, which has a breakthrough drug said to threaten one...
05.08.2015
- Irish pharmaceutical producer Shire has made an offer to buy US drugmaker Baxalta for around $30 billion in stock. With the bid, Shire is said to be trying to solidify its position...
10.04.2015
- The US Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) from Shire for its lifitegrast dry eye treatment for adults and has designated it as a Priority...
23.02.2015
- A former New York-based financial analyst who followed the pharmaceutical industry and is believed to have been employed by Merck & Co has pleaded guilty to participating in an...
21.07.2014
- In its fifth attempt to buy the company, AbbVie, a recent spin-off of US drugmaker Abbott Laboratories, has won the race to acquire European rival Shire, clinching the deal for...
15.07.2014
- Dublin-based pharmaceutical producer Shire, a specialist in drugs to treat rare diseases, has succumbed to an increased £31 billion ($53 billion) takeover offer from US drugmaker...
09.07.2014
- US drugmaker AbbVie has raised its offer for London-based pharmaceutical producer Shire to £30.1 billion ($51.3 billion), hoping to win over its reluctant target after three...
24.06.2014
- British drugmaker Shire has rejected a £27 billion ($46 billion) takeover offer from AbbVie, the latest attempt by a US healthcare firm to tap into lower tax rates abroad via an...
